Takeda Downgrade Looms After Shareholders Approve Shire Deal

(Bloomberg) -- Takeda Pharmaceutical Co. shareholders’ approval of the $62 billion acquisition of Shire Plc is good news for its bosses’ ambitions to build a global drug giant -- but bad news for i...

Bloomberg Quint

Add BloombergQuint App to Home screen.